Hanoch Rappaport

Hanoch Rappaport currently works at Provident Co. of the Employees of the Hebrew University Ltd., as Chief Executive Officer from 2014 and The Hebrew University of Jerusalem, as Chief Financial Officer-Employees Provident Fund.
Mr. Rappaport also formerly worked at Anchiano Therapeutics Ltd., as Director, BioCancell Therapeutics, Inc., as Director from 2006 to 2013, Bank Hapoalim BM, as Corporate Credit Officer, and A. Heifetz & Co., as Investment Manager.
Mr. Rappaport received his Masters Business Admin degree from Tel-Aviv University, Masters Business Admin degree from The Hebrew University of Jerusalem, and undergraduate degree from Bar-Ilan University.